Analyst Viewpoint
High prevalence of diabetes and rise in preference for self-administration are fueling the injection pen market size. Injection pens that provide audible and visual feedback to confirm dose delivery are gaining traction among end-users.
Advanced injection pen technology has been continuously evolving to improve patient comfort and minimize pain during injections. Manufacturers are closely working on including ease of cartilage replacement, injection convenience, insulin-dose setting dial use, and prominence of audio clicks.
These factors are anticipated to improve the performance and quality of insulin injection pens, thereby augmenting the injection pen market development.
Injection pen is a device that is extensively employed to deliver medicine, making the administration more convenient and easier. These pens are preferred over vials and syringes as they enable the delivery of the medicine in shorter intervals of time.
Disposable and reusable are two types of injection pens used for the administration of medicines. Disposable pens contain prefilled insulin cartridges, which are disposed of after usage.
Reusable pens contain an insulin cartridge, which can be replaced once the dose has been administered. Injection pens are employed in the effective treatment of a broad spectrum of medical conditions including diabetes, rheumatoid arthritis, obesity, and insulin deficiency.
| Attribute | Detail |
|---|---|
| Drivers |
|
Injection pens are extensively used by over half of the patient population suffering from insulin-related problems. These pens are an easier and more convenient option for diabetic patients.
According to a 2019 Organization for Economic Co-operation and Development (OECD) report, nearly one in three adults is obese in Britain, the highest rate in Europe.
Injection pen manufacturers are introducing products with color codes to enable patients to distinguish between various insulin formulations. This helps to reduce pen-selection errors considerably.
Approval and launch of obesity drugs are driving the injection pen market demand. In January 2024, Eli Lilly announced to launch Mounjaro drug against obesity and diabetes in the U.K. within weeks after winning clearance for pre-filling it into an injection pen.
Insulin pen devices make it easier and less painful for patients to self-administer daily injections. The high precision and accuracy of the device enables physicians to fine-tune dosage. Insulin pens are easy to use, user-friendly, and highly accurate in insulin delivery.
Additionally, these pens are available in durable or pre-filled designs wherein an interchangeable insulin cartridge is used. The availability of a range of insulin formulations is expected to spur the injection pen market growth in the near future.
Advanced injection pen technology for painless injections is increasingly being used to treat diabetes worldwide and the trend is expected to continue during the forecast period.
The ease of grip provided by injection pens and in performing self-injection procedures has driven the adoption of injection pens over the past few years— an injection pen market trend that is likely to continue in the near future.
According to the latest injection pen market analysis, the disposable type segment accounted for a prominent share in 2022. Growth of the segment can be ascribed to the convenient usage, accurate delivery, and appropriate dosage system of disposable injection pens.
These pends offer multiple doses and result in less infection to patients. Disposable pens are more reliable with fixed prefilled medicines as compared to those with reusable ones.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America dominated the global injection pen market share in 2022. Increase in patient burden suffering from diabetes and surge in adoption of injection pens in-home care settings are driving the market dynamics of the region. Presence of key players offering various injection pens used for autoimmune, growth hormone, and diabetes and pediatric patients is also fueling the injection pen industry statistics in North America.
Injection pen companies are focused on improving the design parameters of products. They are tapping into opportunities across Asia Pacific and North America to establish a solid foothold in these regions. Key players are increasing awareness regarding the benefits of injection pens to gain a competitive edge in the current market landscape.
Manufacturers are adopting outsourcing services to offer affordable products. In 2023, Civica, Inc. selected Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for the company’s affordable insulins.
Lilly, Novo Nordisk, Owen Mumford, Sanofi, F. Hoffman-La Roche Ltd., Merck KGaA, Haselmeier, Gerresheimer AG, BD, and AstraZeneca are key players operating in this market.
The injection pen market report highlights these companies in terms of parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 39.8 Bn |
| Market Forecast Value in 2031 | US$ 73.7 Bn |
| Growth Rate (CAGR) | 7.2% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 39.8 Bn in 2022
It is projected to grow at a CAGR of 7.2% from 2023 to 2031
High prevalence of diabetes and rise in preference for self-administration
The disposable segment dominated in 2022
North America was the most lucrative region in 2022
Lilly, Novo Nordisk, Owen Mumford, Sanofi, F. Hoffman-La Roche Ltd., Merck KGaA, Haselmeier, Gerresheimer AG, BD, and AstraZeneca
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Injection Pen Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Injection Pen Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Injection Pen Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Reusable
6.3.2. Disposable
6.4. Market Attractiveness Analysis, by Type
7. Global Injection Pen Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Diabetes
7.3.2. Growth Hormone Therapy
7.3.3. Autoimmune
7.3.4. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Injection Pen Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Injection Pen Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Injection Pen Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Reusable
10.3.2. Disposable
10.4. Market Value Forecast, by Indication, 2017–2031
10.4.1. Diabetes
10.4.2. Growth Hormone Therapy
10.4.3. Autoimmune
10.4.4. Others
10.5. Market Value Forecast, by Distribution Channel, 2017–2031
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Indication
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Injection Pen Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Reusable
11.3.2. Disposable
11.4. Market Value Forecast, by Indication, 2017–2031
11.4.1. Diabetes
11.4.2. Growth Hormone Therapy
11.4.3. Autoimmune
11.4.4. Others
11.5. Market Value Forecast, by Distribution Channel, 2017–2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Indication
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Injection Pen Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Reusable
12.3.2. Disposable
12.4. Market Value Forecast, by Indication, 2017–2031
12.4.1. Diabetes
12.4.2. Growth Hormone Therapy
12.4.3. Autoimmune
12.4.4. Others
12.5. Market Value Forecast, by Distribution Channel, 2017–2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Indication
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Injection Pen Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Reusable
13.3.2. Disposable
13.4. Market Value Forecast, by Indication, 2017–2031
13.4.1. Diabetes
13.4.2. Growth Hormone Therapy
13.4.3. Autoimmune
13.4.4. Others
13.5. Market Value Forecast, by Distribution Channel, 2017–2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Indication
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Injection Pen Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. Reusable
14.3.2. Disposable
14.4. Market Value Forecast, by Indication, 2017–2031
14.4.1. Diabetes
14.4.2. Growth Hormone Therapy
14.4.3. Autoimmune
14.4.4. Others
14.5. Market Value Forecast, by Distribution Channel, 2017–2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Indication
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Lilly
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Novo Nordisk
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Owen Mumford
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sanofi
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. F. Hoffman-La Roche Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. AstraZeneca
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Merck KGaA
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Haselmeier
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Gerresheimer AG
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. BD
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 03: Global Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 04: Global Injection Pen Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Injection Pen Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 08: North America Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 09: Europe Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 12: Europe Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 16: Asia Pacific Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 17: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 20: Latin America Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 21: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 24: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Injection Pen Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Injection Pen Market Revenue (US$ Mn), by Type, 2022
Figure 03: Global Injection Pen Market Value Share, by Type, 2022
Figure 04: Global Injection Pen Market Revenue (US$ Mn), by Indication, 2022
Figure 05: Global Injection Pen Market Value Share, by Indication, 2022
Figure 06: Global Injection Pen Market Revenue (US$ Mn), by Distribution Channel, 2022
Figure 07: Global Injection Pen Market Value Share, by Distribution Channel, 2022
Figure 08: Global Injection Pen Market Value Share, by Region, 2022
Figure 09: Global Injection Pen Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Injection Pen Market Value Share Analysis, by Type, 2022–2031
Figure 11: Global Injection Pen Market Attractiveness Analysis, by Type, 2023–2031
Figure 12: Global Injection Pen Market Value Share Analysis, by Indication, 2022–2031
Figure 13: Global Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031
Figure 14: Global Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 15: Global Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 16: Global Injection Pen Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Injection Pen Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Injection Pen Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Injection Pen Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Injection Pen Market Value Share Analysis, by Type, 2022–2031
Figure 22: North America Injection Pen Market Value Share Analysis, by Indication, 2022–2031
Figure 23: North America Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 24: North America Injection Pen Market Attractiveness Analysis, by Type, 2023–2031
Figure 25: North America Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031
Figure 26: North America Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 27: Europe Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Injection Pen Market Value Share Analysis, by Type, 2022–2031
Figure 31: Europe Injection Pen Market Value Share Analysis, by Indication, 2022–2031
Figure 32: Europe Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 33: Europe Injection Pen Market Attractiveness Analysis, by Type, 2023–2031
Figure 34: Europe Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031
Figure 35: Europe Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 36: Asia Pacific Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Injection Pen Market Value Share Analysis, by Type, 2022–2031
Figure 40: Asia Pacific Injection Pen Market Value Share Analysis, by Indication, 2022–2031
Figure 41: Asia Pacific Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 42: Asia Pacific Injection Pen Market Attractiveness Analysis, by Type, 2023–2031
Figure 43: Asia Pacific Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031
Figure 44: Asia Pacific Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 45: Latin America Injection Pen Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Injection Pen Market Value Share Analysis, by Type, 2022–2031
Figure 49: Latin America Injection Pen Market Value Share Analysis, by Indication, 2022–2031
Figure 50: Latin America Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 51: Latin America Injection Pen Market Attractiveness Analysis, by Type, 2023–2031
Figure 52: Latin America Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031
Figure 53: Latin America Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 54: Middle East & Africa Injection Pen Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Injection Pen Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Injection Pen Market Value Share Analysis, by Type, 2022–2031
Figure 58: Middle East & Africa Injection Pen Market Value Share Analysis, by Indication, 2022–2031
Figure 59: Middle East & Africa Injection Pen Market Value Share Analysis, by Distribution Channel, 2022–2031
Figure 60: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Type, 2023–2031
Figure 61: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Indication, 2023–2031
Figure 62: Middle East & Africa Injection Pen Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Injection Pen Market
*86 figures and 60 tables includes